ENTERA BIO LTD. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ENTERA BIO LTD. (ENTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 34.36 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 34.36M shares, a 101.30% increase year-over-year.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.32M shares, a 7.02% increase year-over-year.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 17.81M shares, a 3.07% increase year-over-year.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 17.07M shares, a 0.00% change year-over-year.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 17.35M shares, a 3.34% increase from fiscal 2024.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.79M shares, a 125.12% increase from fiscal 2023.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.46M shares, a 19.24% increase from fiscal 2022.
- ENTERA BIO LTD. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.26M shares, a 4.02% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 34.36M shares 10-Q · filed 2026-08-07 | 31.71M shares 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 17.32M shares 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | 17.35M shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 17.81M shares 10-Q · filed 2025-11-14 | 17.02M shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 17.07M shares 10-Q · filed 2026-08-07 | 16.86M shares 10-Q · filed 2025-08-08 | 16.56M shares 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 16.19M shares 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | 16.79M shares 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | 17.28M shares 10-Q · filed 2025-11-14 | 17.14M shares 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | 17.07M shares 10-Q · filed 2025-08-08 | 16.79M shares 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 16.48M shares 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | 7.46M shares 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | 7.00M shares 10-Q · filed 2024-11-08 | 7.24M shares 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | 7.60M shares 10-Q · filed 2024-08-09 | 7.36M shares 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | 7.12M shares 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | 6.26M shares 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | 6.07M shares 10-Q · filed 2023-11-14 | 6.24M shares 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | 6.47M shares 10-Q · filed 2023-08-11 | 6.33M shares 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | 6.24M shares 10-Q · filed 2023-05-05 | ||||
| 2021-12-31 | 6.52M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 5.49M shares 10-Q · filed 2022-11-10 | 7.03M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 7.72M shares 10-Q · filed 2022-08-11 | 7.80M shares 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 7.89M shares 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | 7.22M shares 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |